RTI Surgical™ Hosts Winter Biologics Spine Symposium

Meeting Features Keynote Speaker Dr. Harvinder Sandhu of Hospital for Special Surgery, New York

ALACHUA, Fla.--()--RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, is hosting a surgeon education symposium focused on the use of biologic implants in spine surgery tomorrow in New York.

The symposium will feature keynote speaker Dr. Harvinder Sandhu from the Hospital for Special Surgery in New York who will discuss utilizing current evidence to make informed choices when using bone graft materials. Dr. Sigurd Berven of the University of California, San Francisco, will serve as event chairman. The symposium will also feature presentations from five additional surgeon faculty members from around the country. Presentation topics will include the science behind bone grafting technologies including growth factors, stem cells, allograft and synthetic biologics, and the cost effectiveness of new technologies.

“RTI’s winter spine symposium is promising to be one of the most successful educational programs we’ve hosted this year,” said Brian Hutchison, president and CEO of RTI Surgical. “It’s a privilege to bring this group of esteemed surgeons together and we are excited to facilitate as they examine the science, clinical experience, and policy implications of the choices they make in surgery.”

This meeting is the last in a series of four educational symposia that RTI will host in 2014 as part of the RTI STRIDES (Surgical Training, Research, Investigation, Development, Education and Skill) surgeon education and engagement program.

About RTI Surgical Inc.

RTI Surgical is a leading global surgical implant company providing surgeons with safe biologic, metal and synthetic implants. Committed to delivering a higher standard, RTI’s implants are used in sports medicine, general surgery, spine, orthopedic, trauma and cardiothoracic procedures and are distributed in nearly 50 countries. RTI is headquartered in Alachua, Fla., and has four manufacturing facilities throughout the U.S. and Europe. RTI is accredited in the U.S. by the American Association of Tissue Banks and is a member of AdvaMed. For more information, please visit www.rtix.com.

Forward Looking Statement

This communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s current expectations, estimates and projections about our industry, our management’s beliefs and certain assumptions made by our management. Words such as “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” variations of such words and similar expressions are intended to identify such forward-looking statements. In addition, except for historical information, any statements made in this communication about growth rates, new product introductions, future operational improvements and results or regulatory actions or approvals or changes to agreements with distributors also are forward-looking statements. These statements are not guarantees of future performance and are subject to risks and uncertainties, including the risks described in public filings with the U.S. Securities and Exchange Commission (SEC). In addition, these statements are subject to risks associated with Pioneer’s financial condition, business and operations and the integration of Pioneer’s business with ours. Our actual results may differ materially from the anticipated results reflected in these forward-looking statements. Copies of the company’s SEC filings may be obtained by contacting the company or the SEC or by visiting RTI’s website at www.rtix.com or the SEC’s website at www.sec.gov.

Contacts

RTI Surgical Inc.
Jenny Highlander, APR, CPRC, 386-418-8888
Director, Corporate Communications
jhighlander@rtix.com

Contacts

RTI Surgical Inc.
Jenny Highlander, APR, CPRC, 386-418-8888
Director, Corporate Communications
jhighlander@rtix.com